𝔖 Bobbio Scriptorium
✦   LIBER   ✦

9162 EGFR, KRAS, PIK3CA mutations and response to tyrosine kinase inhibitors (TKIs) in advanced NSCLC patients

✍ Scribed by Chiari, R.; Ludovini, V.; Bianconi, F.; Pistola, L.; Colella, R.; Mameli, M.; Giuffrida, D.; Tofanetti, F.R.; Flacco, A.; Crinò, L.


Book ID
122803245
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
51 KB
Volume
7
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES